Chronic Lymphocyte Leukemia
1 clinical trials · Condition
◉ Watch Chronic Lymphocyte Leukemia
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia (NCT02232386) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-03-02 |
Track Chronic Lymphocyte Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.